Founded in 2002, Taibang Biologic Group (“Taibang”) is a leading Chinese biopharmaceutical company that provides a comprehensive range of plasma-derived products. The company's core business includes the development, manufacture and sale of plasma-derived products and other biopharmaceutical products.

As a leader in China's plasma-derived products industry, Taibang possesses leading international technology, one of the largest manufacturing capacities for plasma-derived products in Asia, and world-class R&D capabilities. The company's industry-leading product portfolio currently includes 10 plasma-derived products covering more than 20 specifications in three main categories: human albumin, human immunoglobulin, and human coagulation factors.